GetTopicDetailResponse(id=4397e520618, topicName=移植物抗宿主病（GVHD）, introduction=移植物抗宿主?。℅VHD）, content=null, image=null, comments=3, allHits=1296, url=https://h5.medsci.cn/topic?id=75206, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=12625, tagList=[TagDto(tagId=12625, tagName=移植物抗宿主病（GVHD）)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2259407, encodeId=9c6e225940e18, content=<a href='/topic/show?id=850849e666e' target=_blank style='color:#2F92EE;'>#異基因造血干細胞移植#</a> <a href='/topic/show?id=4397e520618' target=_blank style='color:#2F92EE;'>#移植物抗宿主?。℅VHD）#</a>, objectTitle=警惕造血干細胞移植后的"隱形殺手"：中樞神經系統(tǒng)移植物抗宿主病, objectType=article, longId=870850, objectId=01048e0850c7, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/multiple-sclerosis-s13-mri-brain-and-spinal-cord.jpg, objectUrl=/article/show_article.do?id=01048e0850c7, replyNumber=0, likeNumber=39, createdTime=2025-04-07, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=01048e0850c7, moduleTitle=警惕造血干細胞移植后的"隱形殺手"：中樞神經系統(tǒng)移植物抗宿主病, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=01048e0850c7)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1422163, encodeId=d15514221630f, content=<a href='/topic/show?id=4397e520618' target=_blank style='color:#2F92EE;'>#移植物抗宿主?。℅VHD）#</a>, objectTitle=移植物抗宿主?。℅VHD）新藥開發(fā)攻略, objectType=article, longId=200195, objectId=647b2001953f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=647b2001953f, replyNumber=0, likeNumber=125, createdTime=2020-09-05, rootId=0, userName=surilei, userId=8ac13684742, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=647b2001953f, moduleTitle=移植物抗宿主病（GVHD）新藥開發(fā)攻略, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=647b2001953f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422162, encodeId=1d3d142216205, content=<a href='/topic/show?id=4397e520618' target=_blank style='color:#2F92EE;'>#移植物抗宿主?。℅VHD）#</a>, objectTitle=Blood：耗竭TCRαβ+/CD19+細胞可有效預防移植物抗宿主病(GVHD)，同時降低對供體匹配度的要求, objectType=article, longId=180391, objectId=f6531803912c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f6531803912c, replyNumber=0, likeNumber=97, createdTime=2019-10-04, rootId=0, userName=surilei, userId=8ac13684742, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f6531803912c, moduleTitle=Blood：耗竭TCRαβ+/CD19+細胞可有效預防移植物抗宿主病(GVHD)，同時降低對供體匹配度的要求, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=f6531803912c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422161, encodeId=fb3c14221615a, content=<a href='/topic/show?id=4397e520618' target=_blank style='color:#2F92EE;'>#移植物抗宿主?。℅VHD）#</a>, objectTitle=FDA授予Jakavi（魯索替尼）治療急性移植物抗宿主病（GVHD）的突破性藥物資格, objectType=article, longId=71612, objectId=40d3e1612a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=40d3e1612a3, replyNumber=0, likeNumber=134, createdTime=2016-06-27, rootId=0, userName=surilei, userId=8ac13684742, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=40d3e1612a3, moduleTitle=FDA授予Jakavi（魯索替尼）治療急性移植物抗宿主?。℅VHD）的突破性藥物資格, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=40d3e1612a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
